Has Charles Jobin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $506,028 in general payments to Charles Jobin, MD across 491 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Jobin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Jobin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Jobin, MD

Orthopaedic Surgery · New York, NYNPI 1770740342

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.2%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 60.1% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $193,036, 9.1 times the $21,237 reported in 2019. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$506,028in general payments, 2019–2025

Across 491 payments — averaging $1030.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$304K
Zimmer Biomet$179K
Medical Device Business Services, Inc.$10K
Acumed LLC$9K
Synthes GmbH$2K
Integra Lifesciences Corporation$1K
plus $1K from 7 others

$35,000in research payments, 2019–2025

Across 4 payments — averaging $8750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Acumed LLC$35K

What the payments were for

Royalty or licence$200,20740%
Consulting fees$258,88151%
Speaking & faculty fees$18,3984%
Travel & lodging$20,4794%
Food & beverage$8,0162%
Entertainment$480%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	132	$304,143
Zimmer Biomet	300	$178,855
Medical Device Business Services, Inc.	9	$9,525
Acumed LLC	11	$8,778
Synthes GmbH	4	$2,187
Integra Lifesciences Corporation	19	$1,242
Stryker	7	$753
Novastep Inc.	1	$150
Medtronic	1	$138
Johnson & Johnson	3	$134
Gotham Surgical Solutions & Devices, Inc.	2	$59
Shoulder Innovations, Inc.	1	$48
Bioventus LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AETOS Shoulder System$265,863
Comprehensive Anatomic$32,273
Comprehensive Reverse$29,273
Comprehensive Shoulder System$15,874
Bioinductive Implant with Arthroscopic Delivery System - Medium$15,124
ACUMED$6,629
TWINFIX$5,642
PD-Extremities-New Product$4,500
Signature Glenoid Guides$3,500
Anatomic Radial Head System$2,250
Elbow Plating System$2,250
Affixus$1,731
REAL INTELLIGENCE$1,314
RI.HIP NAVIGATION$1,314
Journey II$1,314
JOURNEY$1,314
PROMOS$1,178
Cannulated Screw System$675
Persona$671
HIP7$611

How this compares

$506,028 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$453,522

Medicare patients

614

Services billed

4,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	327	$1,229
Gabapentin	46	$433
Oxycodone Hcl	15	$67
Tramadol Hcl	11	$29

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

Anthony RomeoNew York$26.8M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$13.2M
William RicciNew York$11.6M
Steven HaasNew York$11.3M
Giles ScuderiNew York$10.7M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$7.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →